Qingdao Wanming Biocell Pharmaceutics Co.,ltd.

This phase II trial is testing whether an investigational eye drop called G01 can protect the optic nerve and slow vision loss in people with primary open-angle glaucoma. The study includes 90 adults with glaucoma who show signs of disease progression. Participants will receive e…